Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 1;22(1):70-78.

The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective

Amish Chinoy  1   2 , Grace R Vassallo  3   4 , Emma Burkitt Wright  2   3 , Judith Eelloo  3 , Siobhan West  3   4 , Eileen Hupton  3 , Paula Galloway  5 , Amy Pilkington  5 , Raja Padidela  1   2 , M Zulf Mughal  1   2   3
Affiliations
Review

The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective

Amish Chinoy et al. J Musculoskelet Neuronal Interact. .

Abstract

Neurofibromatosis type 1 (NF1) can affect multiple systems in the body. An under recognised phenotype is one of muscle weakness. Clinical studies using dynamometry and jumping mechanography have demonstrated that children with NF1 are more likely to have reduced muscle force and power. Many children with NF1 are unable to undertake physical activities to the same level as their peers, and report leg pains on physical activity and aching hands on writing. Children and adolescents with NF1 reporting symptoms of muscle weakness should have a focused assessment to exclude alternative causes of muscle weakness. Assessments of muscle strength and fine motor skills by physiotherapists and occupational therapists can provide objective evidence of muscle function and deficits, allowing supporting systems in education and at home to be implemented. In the absence of an evidence base for management of NF1-related muscle weakness, we recommend muscle-strengthening exercises and generic strategies for pain and fatigue management. Currently, trials are underway involving whole-body vibration therapy and carnitine supplementation as potential future management options.

Keywords: Fatigue; Motor Skills; Muscle; NF1; Strength.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest.

References

    1. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A(2):327–32. - PubMed
    1. Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005;141(1):71–4. - PubMed
    1. Gutmann DH, Wood DL, Collins FS. Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A. 1991;88(21):9658–62. - PMC - PubMed
    1. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Neurofibromatosis 1988. Bethesda, Md., USA July 13-15. 1987;1(3):172–8. - PubMed
    1. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007;6(4):340–51. - PubMed